EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates

Carlo Tascini, Gabriele Bianco iD, Robert A Bonomo, Paolo Gaibani iD

Journal of Antimicrobial Chemotherapy · 2026

DOI: 10.1093/jac/dkaf467 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2026. Verfasst von Carlo Tascini und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Università degli Studi di Udine, Udine, Italy. Hauptthemen laut MEDLINE: Acinetobacter baumannii, Azabicyclo Compounds, Anti-Bacterial Agents, Sulbactam. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: RFU.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

To evaluate the in vitro activity of cefepime in association with a β-lactamase inhibitor (enmetazobactam) or β-lactam enhancer (BLE), zidebactam, against carbapenem-resistant Acinetobacter baumannii (CRAB) strains susceptible or resistant to sulbactam/durlobactam. Material and methods Twenty-one CRAB clinical isolates were characterized by WGS and AST to cefepime/enmetazobactam, cefepime/zidebactam and comparators was determined.

Results

Resistome analysis revealed that all CRAB carried blaOXA-23 carbapenemase genes, while blaADC-25 and blaOXA-66 β-lactamase genes were observed exclusively in sulbactam/durlobactam-resistant strains. Analysis of penicillin-binding protein genes demonstrated the presence of specific mutations within PBP3 (N392T) previously associated to the resistance to sulbactam/durlobactam. Phenotypic analysis revealed that cefepime/enmetazobactam did not exert antibacterial activity against CRAB, while cefepime/zidebactam displayed potent bactericidal activity against both sulbactam/durlobactam-susceptible and -resistant strains.

Conclusions

These results demonstrate that cefepime/zidebactam exhibited potent in vitro antibacterial activity against CRAB producing OXA carbapenemase and support its clinical use against both sulbactam/durlobactam-susceptible or -resistant isolates.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acinetobacter baumanniiAzabicyclo CompoundsAnti-Bacterial AgentsSulbactamCefepimeCyclooctanesPiperidinesDrug Resistance, Multiple, BacterialMicrobial Sensitivity TestsHumansbeta-LactamasesAcinetobacter InfectionsBacterial Proteinsbeta-Lactamase InhibitorsThird Generation CephalosporinsWhole Genome SequencingDrug Combinations

Substanzen

Azabicyclo CompoundsAnti-Bacterial AgentsSulbactamCefepimebeta-LactamasesCyclooctanesBacterial Proteinsbeta-Lactamase InhibitorsdurlobactamPiperidines

Autor:innen und Institutionen

  • Department of Medicine, Università degli Studi di Udine, Udine, Italy.
  • Infectious Diseases Unit, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy.
  • Department of Experimental Medicine, University of Salento, Lecce, Italy.
  • Microbiology and Virology Unit, Vito Fazzi Hospital, Lecce, Italy.
  • Department of Population and Quantitative Health Sciences, School of Medicine, Case Western Reserve University, Cleveland, USA.
  • Department of Diagnostic and Public Health, Microbiology Section, Verona University, Verona, Italy.

ORCID-Profile: Gabriele Bianco, Paolo Gaibani

Förderung

  • RFU

Zitieren

APA

Tascini, C., Bianco, G., Bonomo, R. A., & Gaibani, P. (2026). In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkaf467

Vancouver

Tascini C, Bianco G, Bonomo RA, Gaibani P. In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates. Journal of Antimicrobial Chemotherapy. 2026. doi:10.1093/jac/dkaf467

BibTeX
@article{Tascini2026,
  author = {Tascini, Carlo and Bianco, Gabriele and Bonomo, Robert A and Gaibani, Paolo},
  title = {In vitro activity of cefepime/zidebactam against sulbactam/durlobactam-susceptible and -resistant Acinetobacter baumannii clinical isolates},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2026},
  doi = {10.1093/jac/dkaf467}
}
Kostenlos starten →